These dashboards display all Special Access Scheme Category A (SAS A) notifications and Special Access Scheme Category B (SAS B) applications received for medicinal cannabis products by the TGA.
SAS A notifications
The SAS A pathway allows medical practitioners to access therapeutic goods that are not included in the Australian Register of Therapeutic Goods (ARTG) for a single patient who is seriously ill with a condition from which death is reasonably likely to occur within a matter of months, or from which premature death is reasonably likely to occur in the absence of early treatment.
The SAS B pathway allows medical practitioners to access therapeutic goods that are not included in the Australian Register of Therapeutic Goods (ARTG)for a single patient where the SAS Category A or SAS Category C pathways are not applicable.
Filters can be applied to the data by clicking on the graphs to refine results and capture the desired data. Any filter applied that produces a result less than 10 will display ‘<10’ instead of the exact number, to ensure anonymity of individuals. Filters can be removed by clicking the ‘Clear Selections’ button. Filtered data can be exported into an excel spreadsheet by clicking the ‘Bulk Export’ button.
The dashboards are best viewed on a desktop.
Category based approvals
Medicinal cannabis category-based approvals came into effect November 2021 and applications approved prior to this date were tradename based. As they cannot be assessed under the individual categories these approvals have been grouped under the 'Pre-Category Approval' heading.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.